OptimizeRx Corp Balance Sheet
OPRX|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
OptimizeRx Corp had $177M in total assets and $117M in shareholders' equity as of FY2025. Total debt was $26M against $23M in cash, resulting in $3M net debt.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23.4M | $13.4M | $13.9M | $18.2M | $10.5M | $10.5M | $8.9M | $5.1M | $7.0M | $8.2M | $3.4M | $1.1M | $284.3K | $284.3K | $959.2K |
| Accounts Receivable | $38.2M | $38.2M | $36.3M | $22.2M | $17.9M | $17.9M | $7.4M | $6.5M | $2.3M | $3.1M | $2.8M | $2.1M | - | - | - |
| Current Assets | $64.7M | $54.0M | $54.3M | $98.6M | $32.9M | $32.9M | $27.1M | $16.0M | $8.8M | $10.2M | $11.1M | $5.6M | $2.7M | $969.2K | $1.6M |
| PP&E (Net) | $106.0K | $150.0K | $149.4K | $137.4K | $148.9K | $148.9K | $176.0K | $149.3K | $167.3K | $173.6K | $10.2K | $12.8K | $15.1K | $20.7K | $23.9K |
| Goodwill | $70.9M | $78.4M | $22.7M | $14.7M | $14.7M | $14.7M | $14.7M | $3.7M | - | - | - | - | - | - | - |
| Total Assets | $176.9M | $171.2M | $183.4M | $134.7M | $60.3M | $60.3M | $56.6M | $25.1M | $9.8M | $11.5M | $12.3M | $7.0M | $4.0M | $2.2M | $2.9M |
| Current Liabilities | $21.3M | $18.7M | $17.9M | $8.4M | $10.0M | $10.0M | $6.1M | $4.2M | $3.5M | $3.7M | $3.4M | $2.4M | $2.0M | $679.9K | $1.3M |
| Total Debt | $26.3M | $34.3M | $38.3M | - | - | - | - | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $117.0M | $126.6M | $126.1M | $131.4M | $44.9M | $44.9M | $18.5M | $6.2M | $7.8M | $8.9M | $4.6M | $1.7M | $1.4M | $1.6M | - |